Drug:
Reaction: OVERDOSE
20250101 - 20251231
No. 2001 - 2100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 2001 | 25420187 |
CH |
2 | |
Overdose, Device breakage, |
||||
| 2002 | 25422840 |
29 | 2 | |
Liver function test increased, Hypotension, Tachycardia, Overdose, Hypertransaminasaemia, |
||||
SERTRALINE HYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, HYDROXYZINE, |
||||
| 2003 | 25422842 |
71 | 1 | |
Respiratory depression, Overdose, |
||||
MORPHINE SULFATE, |
||||
| 2004 | 25410648 |
US |
73 | 2 |
Seizure, Fall, Overdose, Off label use, |
||||
BRIVARACETAM, BRIVARACETAM, |
||||
| 2005 | 25410657 |
US |
15 | 2 |
Overdose, |
||||
ZOLPIDEM TARTRATE, AMLODIPINE, CLONAZEPAM, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, TRANEXAMIC ACID, |
||||
| 2006 | 25411044 |
US |
14 | 2 |
Haemodynamic instability, Seizure, Conduction disorder, Overdose, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 2007 | 25411050 |
US |
81 | 2 |
Overdose, Extra dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 2008 | 25411243 |
US |
85 | 2 |
Pneumonia bacterial, Hypoacusis, Respiratory fume inhalation disorder, Injection site pain, Product use in unapproved indication, Overdose, |
||||
DUPILUMAB, DUPILUMAB, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, FEXOFENADINE HYDROCHLORIDE, |
||||
| 2009 | 25411764 |
US |
76 | 2 |
Dizziness, Heart rate increased, Intentional product use issue, Drug dose omission by device, Overdose, |
||||
TERIPARATIDE, TERIPARATIDE, |
||||
| 2010 | 25411861 |
US |
2 | |
Overdose, |
||||
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 2011 | 25412962 |
AU |
||
Cardiotoxicity, Hypokalaemia, Hypoglycaemia, Overdose, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 2012 | 25412984 |
JP |
62 | 1 |
Haemorrhage, Fall, Overdose, |
||||
| 2013 | 25413424 |
US |
||
Psychotic disorder, Overdose, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, |
||||
| 2014 | 25414048 |
US |
2 | |
Vertigo, Device use issue, Device defective, Device delivery system issue, Incorrect dose administered by device, Product dose omission issue, Overdose, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
| 2015 | 25414061 |
US |
1 | |
Overdose, Intentional product misuse, Wrong technique in product usage process, Wrong technique in product usage process, Product prescribing issue, Incorrect dose administered by device, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, |
||||
| 2016 | 25414077 |
CA |
36 | 1 |
Overdose, Toxicity to various agents, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, CAFFEINE, CAFFEINE, CAFFEINE, CAFFEINE, FENTANYL, FENTANYL, FENTANYL, FENTANYL, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 2017 | 25414080 |
PL |
18 | 1 |
Suicide attempt, Loss of consciousness, Mechanical ventilation, Toxicity to various agents, Drug abuse, Overdose, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VALPROIC ACID, VALPROIC ACID, VALPROIC ACID, VALPROIC ACID, |
||||
| 2018 | 25414118 |
PL |
58 | 2 |
Psychomotor retardation, Asthenia, Suicide attempt, Somnolence, Toxicity to various agents, Drug abuse, Overdose, |
||||
ZOLPIDEM TARTRATE, |
||||
| 2019 | 25414150 |
PL |
18 | 1 |
Suicide attempt, Somnolence, Toxicity to various agents, Drug abuse, Overdose, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, |
||||
| 2020 | 25414152 |
CA |
64 | 2 |
Overdose, Toxicity to various agents, |
||||
SERTRALINE, SERTRALINE, SERTRALINE, SERTRALINE, AMPHETAMINE, AMPHETAMINE, AMPHETAMINE, AMPHETAMINE, BUPRENORPHINE, BUPRENORPHINE, BUPRENORPHINE, BUPRENORPHINE, CAFFEINE, CAFFEINE, CAFFEINE, CAFFEINE, FENTANYL, FENTANYL, FENTANYL, FENTANYL, NALOXONE, NALOXONE, NALOXONE, NALOXONE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 2021 | 25414751 |
JP |
8 | 2 |
Respiratory depression, Altered state of consciousness, Overdose, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, FENTANYL CITRATE, |
||||
| 2022 | 25414889 |
US |
12 | |
Overdose, No adverse event, |
||||
| 2023 | 25415069 |
CH |
28 | 1 |
Necrotising oesophagitis, Overdose, |
||||
QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, |
||||
| 2024 | 25410180 |
US |
2 | |
Product dose omission issue, Feeling abnormal, Inappropriate schedule of product administration, Overdose, |
||||
IXEKIZUMAB, |
||||
| 2025 | 25408718 |
US |
13 | 2 |
Cardiac dysfunction, Metabolic acidosis, Hyperlactacidaemia, Acute kidney injury, Overdose, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 2026 | 25408983 |
US |
1 | |
Incorrect dose administered, Overdose, Product dose omission issue, |
||||
ALBUTEROL SULFATE AND BUDESONIDE, |
||||
| 2027 | 25409056 |
FR |
15 | 1 |
Atrial fibrillation, Bradycardia, Sinus node dysfunction, Overdose, Drug ineffective, Chronotropic incompetence, Intentional product use issue, Product use issue, Off label use, |
||||
BISOPROLOL FUMARATE, ATROPINE SULFATE, ATROPINE, RIVAROXABAN, |
||||
| 2028 | 25409725 |
US |
40 | 1 |
Overdose, Endotracheal intubation complication, Respiratory acidosis, |
||||
TADALAFIL, FENTANYL, |
||||
| 2029 | 25409726 |
US |
54 | 2 |
Overdose, Endotracheal intubation complication, Vomiting, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, NAPROXEN, NAPROXEN SODIUM, QUININE, FENTANYL, |
||||
| 2030 | 25409727 |
US |
63 | 1 |
Overdose, Endotracheal intubation complication, White matter lesion, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, GLIMEPIRIDE, HALOPERIDOL, HALOPERIDOL LACTATE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, RISPERIDONE, FENTANYL, |
||||
| 2031 | 25409732 |
US |
32 | 2 |
Overdose, Endotracheal intubation complication, |
||||
AMPHETAMINE, HYDROXYZINE, QUININE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, FENTANYL, |
||||
| 2032 | 25409733 |
US |
23 | 2 |
Overdose, Endotracheal intubation complication, Pneumocephalus, |
||||
ALPRAZOLAM, OXYCODONE, QUININE, FENTANYL, |
||||
| 2033 | 25409734 |
US |
41 | 1 |
Overdose, Endotracheal intubation complication, Haematemesis, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, QUININE, LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, FENTANYL, |
||||
| 2034 | 25403801 |
GB |
||
Iritis, Eye pain, Overdose, Intentional product use issue, |
||||
INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 2035 | 25404555 |
US |
1 | |
Drug delivery system issue, Incorrect dose administered by device, Overdose, Eye disorder, |
||||
BUDESONIDE, GLYCOPYRROLATE, AND FORMOTEROL FUMARATE, |
||||
| 2036 | 25404569 |
US |
8 | 1 |
Overdose, |
||||
LORATADINE, LORATADINE ORAL, |
||||
| 2037 | 25404945 |
FR |
57 | 2 |
Cardiogenic shock, Poisoning, Overdose, |
||||
ALPRAZOLAM, DAPAGLIFLOZIN, BISOPROLOL FUMARATE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, |
||||
| 2038 | 25405138 |
CA |
||
Loss of consciousness, Incoherent, Overdose, |
||||
ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, GOLIMUMAB, GABAPENTIN, |
||||
| 2039 | 25405154 |
AU |
||
Cardiotoxicity, Hypoglycaemia, Overdose, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 2040 | 25405533 |
US |
||
Hallucination, visual, Overdose, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 2041 | 25405652 |
CA |
43 | 1 |
Hallucination, auditory, Dysphonia, Tooth injury, Tendon disorder, Drug ineffective for unapproved indication, Sexual dysfunction, Hypoaesthesia, Ear pain, Blood prolactin increased, Toothache, Overdose, Mental disorder, Screaming, Impaired quality of life, Impaired work ability, Product use in unapproved indication, Anxiety, Hypotension, Aggression, Bruxism, Libido disorder, Back disorder, Limb discomfort, Ear disorder, Physical disability, Aphonia, Alexithymia, Incoherent, Somnolence, Suicidal ideation, Housebound, Asthenia, Arthropathy, Loss of employment, |
||||
PALIPERIDONE PALMITATE, PALIPERIDONE PALMITATE, CLONAZEPAM, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, ARIPIPRAZOLE, |
||||
| 2042 | 25405680 |
CA |
||
Brain neoplasm, Intentional product use issue, Overdose, |
||||
| 2043 | 25405690 |
69 | 2 | |
Overdose, Inappropriate schedule of product administration, Product prescribing error, Drug interaction, Bone marrow failure, Mucosal inflammation, Septic shock, |
||||
METHOTREXATE, METHOTREXATE SODIUM, LANSOPRAZOLE, LANSOPRAZOLE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2044 | 25406126 |
CA |
30 | 1 |
Toxicity to various agents, Overdose, |
||||
GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, AMPHETAMINE, AMPHETAMINE, AMPHETAMINE, AMPHETAMINE, CAFFEINE, CAFFEINE, CAFFEINE, CAFFEINE, FENTANYL, FENTANYL, FENTANYL, FENTANYL, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, OLANZAPINE, OLANZAPINE, OLANZAPINE, OLANZAPINE, |
||||
| 2045 | 25406214 |
US |
2 | |
Lip swelling, Swelling face, Drug ineffective, Overdose, Drug interaction, |
||||
FEXOFENADINE HYDROCHLORIDE, CALCIUM CARBONATE, |
||||
| 2046 | 25406694 |
US |
||
Incorrect route of product administration, Overdose, Inappropriate schedule of product administration, |
||||
INCOBOTULINUMTOXINA, |
||||
| 2047 | 25406698 |
US |
82 | 1 |
Product package associated injury, Overdose, Product packaging difficult to open, |
||||
CETIRIZINE HYDROCHLORIDE, |
||||
| 2048 | 25406825 |
IR |
77 | 2 |
Platelet count decreased, Toxicity to various agents, Stomatitis, Leukopenia, Petechiae, Blood creatinine increased, Inappropriate schedule of product administration, Pharyngeal inflammation, Conjunctival hyperaemia, Electrocardiogram T wave inversion, Skin lesion, Overdose, |
||||
METHOTREXATE, METHOTREXATE SODIUM, GLYBURIDE, |
||||
| 2049 | 25407106 |
US |
2 | |
Overdose, |
||||
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 2050 | 25407248 |
US |
2 | 2 |
Psychomotor hyperactivity, Sleep disorder, Overdose, Product prescribing error, |
||||
SAPROPTERIN DIHYDROCHLORIDE, SAPROPTERIN DIHYDROCHLORIDE, |
||||
| 2051 | 25407345 |
US |
2 | |
Overdose, |
||||
OXYCODONE HYDROCHLORIDE, |
||||
| 2052 | 25407453 |
US |
1 | |
Overdose, Drug dependence, |
||||
OXYCODONE HYDROCHLORIDE, |
||||
| 2053 | 25407466 |
US |
1 | |
Overdose, Drug dependence, |
||||
OXYCODONE HYDROCHLORIDE, |
||||
| 2054 | 25407511 |
US |
2 | 1 |
Gastroenteritis viral, Overdose, Product prescribing error, |
||||
SAPROPTERIN DIHYDROCHLORIDE, |
||||
| 2055 | 25407513 |
US |
1 | |
Illness, Pyrexia, Decreased appetite, Product dose omission in error, Overdose, Product prescribing error, |
||||
SAPROPTERIN DIHYDROCHLORIDE, |
||||
| 2056 | 25407556 |
US |
||
Overdose, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 2057 | 25407565 |
AU |
||
Cardiotoxicity, Hypoglycaemia, Overdose, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 2058 | 25407618 |
AU |
||
Cardiotoxicity, Hypokalaemia, Hypoglycaemia, Overdose, |
||||
INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, PROPRANOLOL HYDROCHLORIDE, |
||||
| 2059 | 25407939 |
BR |
15 | 2 |
Chronic respiratory failure, Pneumonia, Menstruation delayed, Inappropriate schedule of product administration, Wrong technique in product usage process, Bronchial disorder, Weight increased, Dermatitis contact, Overdose, Infusion site erythema, Infusion site swelling, |
||||
| 2060 | 25408009 |
CA |
60 | 1 |
Toxicity to various agents, Overdose, |
||||
AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, CAFFEINE, CAFFEINE, CAFFEINE, CAFFEINE, FENTANYL, FENTANYL, FENTANYL, FENTANYL, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, |
||||
| 2061 | 25408010 |
CA |
52 | 1 |
Overdose, Toxicity to various agents, |
||||
AMLODIPINE, AMLODIPINE, AMLODIPINE, AMLODIPINE, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, CAFFEINE, CAFFEINE, CAFFEINE, CAFFEINE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, CYCLOBENZAPRINE, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, ALCOHOL, ETHYL ALCOHOL, ISOPROPYL ALCOHOL, FENTANYL, FENTANYL, FENTANYL, FENTANYL, NALOXONE, NALOXONE, NALOXONE, NALOXONE, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, NICOTINE POLACRILEX, NICOTINE, NICOTINE POLACRILEX MINI, NICOTINE POLARILEX, |
||||
| 2062 | 25408676 |
GB |
28 | 2 |
Depressed mood, Suicidal behaviour, Mood swings, Fatigue, Overdose, Agitation, |
||||
TIRZEPATIDE, PROGESTERONE, SERTRALINE, |
||||
| 2063 | 25412211 |
31 | 1 | |
Overdose, Product dispensing error, Insomnia, |
||||
| 2064 | 25399092 |
US |
44 | 1 |
Overdose, Incorrect product administration duration, |
||||
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 2065 | 25399432 |
US |
1 | |
Drug ineffective, Overdose, |
||||
GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE, |
||||
| 2066 | 25399645 |
JP |
45 | 1 |
Pneumonia, Dyspnoea, Cough, Overdose, |
||||
TREPROSTINIL, TREPROSTINIL, |
||||
| 2067 | 25399748 |
US |
1 | |
Dementia Alzheimer^s type, Off label use, Incorrect dose administered, Overdose, |
||||
HALOPERIDOL DECANOATE, |
||||
| 2068 | 25399866 |
CA |
40 | 2 |
Nausea, Ill-defined disorder, Type 2 diabetes mellitus, Swelling, Injection site reaction, Pemphigus, Psoriatic arthropathy, Systemic lupus erythematosus, Overdose, C-reactive protein increased, Rheumatoid arthritis, Pericarditis, Contraindicated product administered, Drug ineffective, Drug hypersensitivity, Rash, Onychomadesis, Wound, Dyspnoea, Infusion related reaction, C-reactive protein abnormal, Synovitis, Product use in unapproved indication, Therapeutic product effect incomplete, Confusional state, Intentional product use issue, Product use issue, Treatment failure, Pain, Therapeutic product effect decreased, Underdose, Rheumatic fever, Onychomycosis, Sleep disorder, Off label use, Intentional product use issue, Intentional product use issue, |
||||
METHOTREXATE SODIUM, METHOTREXATE SODIUM, MEPOLIZUMAB, APREMILAST, MINOCYCLINE, MINOCYCLINE, GOLIMUMAB, GOLIMUMAB, HYDROCORTISONE SODIUM SUCCINATE, TRAMADOL HYDROCHLORIDE, SECUKINUMAB, INFLIXIMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, LAMOTRIGINE, LAMOTRIGINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, AZATHIOPRINE SODIUM, CANDESARTAN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, OXYCODONE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, ATOMOXETINE HYDROCHLORIDE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, MAGNESIUM CITRATE ORAL SOLUTION, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, GOLIMUMAB, GOLIMUMAB, BUPRENORPHINE, POVIDONE-IODINE, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, METHOTREXATE SODIUM, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, RANITIDINE, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, RITUXIMAB-ABBS, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ERGOCALCIFEROL, ERENUMAB-AOOE, ADALIMUMAB, ADALIMUMAB, NEOMYCIN SULFATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, MIRABEGRON, MIRABEGRON, VITAMIN A, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, BOTULINUM TOXIN TYPE A, RAMIPRIL, RAMIPRIL, RAMIPRIL, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, HYDROXYCHLOROQUINE SULFATE, DIATRIZOATE MEGLUMINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, CORTISONE ACETATE, CORTISONE ACETATE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, |
||||
| 2069 | 25400451 |
US |
2 | |
Prescription drug used without a prescription, Overdose, Product prescribing error, |
||||
SAPROPTERIN DIHYDROCHLORIDE, SAPROPTERIN DIHYDROCHLORIDE, |
||||
| 2070 | 25400595 |
US |
2 | |
Attention deficit hyperactivity disorder, Overdose, Product prescribing error, |
||||
SAPROPTERIN DIHYDROCHLORIDE, AMITRIPTYLINE HYDROCHLORIDE, DROSPIRENONE AND ETHINYL ESTRADIOL TABLETS, |
||||
| 2071 | 25400738 |
FR |
68 | 2 |
Agranulocytosis, Overdose, White blood cell count decreased, Erythroblast count increased, |
||||
DAPTOMYCIN, LANSOPRAZOLE, AMOXICILLIN, AMOXICILLIN, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ENOXAPARIN SODIUM, AMOXICILLIN AND CLAVULANATE POTASSIUM, DOXYCYCLINE, DOXYCYCLINE HYCLATE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MEROPENEM, |
||||
| 2072 | 25400979 |
JP |
3 | 2 |
Overdose, Toxicity to various agents, |
||||
LORAZEPAM, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, OLANZAPINE, |
||||
| 2073 | 25401262 |
US |
3 | 1 |
Overdose, Contraindicated product administered, |
||||
NALTREXONE, |
||||
| 2074 | 25401578 |
US |
||
Pain, Overdose, Off label use, |
||||
LIDOCAINE, LIDOCAINE HYDROCHLORIDE, BURN RELIEF, MAXIMUM STRENGTH PAIN RELIEVER, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE, LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE, LIDOCAINE 4%, LIDOCAINE, MENTHOL, |
||||
| 2075 | 25401615 |
AU |
||
Acute hepatic failure, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2076 | 25402378 |
US |
76 | 1 |
Atrial fibrillation, Cerebrovascular accident, Wrong technique in device usage process, Incorrect dose administered, Overdose, Intentional dose omission, Product complaint, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 2077 | 25402620 |
FR |
17 | 2 |
Abdominal pain, Vomiting, Overdose, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2078 | 25402866 |
US |
2 | 2 |
Accidental exposure to product by child, Victim of homicide, Overdose, |
||||
OXYCODONE HYDROCHLORIDE, OXYCODONE, |
||||
| 2079 | 25402894 |
US |
2 | |
Head injury, Subdural haematoma, Fall, Therapeutic product effect decreased, Overdose, Inappropriate schedule of product administration, |
||||
VALBENAZINE, VALBENAZINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, GABAPENTIN, LEVOTHYROXINE SODIUM, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, PROMETHAZINE, |
||||
| 2080 | 25403570 |
US |
1 | |
Wrong technique in device usage process, Overdose, Product confusion, Product prescribing error, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, |
||||
| 2081 | 25393516 |
AU |
||
Overdose, Cardiac arrest, Hypoxia, Multiple organ dysfunction syndrome, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, BACLOFEN, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, PROPRANOLOL HYDROCHLORIDE, PROPRANOLOL HYDROCHLORIDE, TEMAZEPAM, |
||||
| 2082 | 25393551 |
US |
1 | |
Overdose, Product prescribing error, Therapy non-responder, |
||||
SAPROPTERIN DIHYDROCHLORIDE, SAPROPTERIN DIHYDROCHLORIDE, |
||||
| 2083 | 25393609 |
US |
1 | 1 |
Viral infection, Overdose, Product prescribing error, Illness, |
||||
SAPROPTERIN DIHYDROCHLORIDE, |
||||
| 2084 | 25393868 |
IR |
2 | |
Toxicity to various agents, Serotonin syndrome, Overdose, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 2085 | 25393870 |
IR |
23 | 2 |
Toxicity to various agents, Atrioventricular block first degree, Arrhythmia, Overdose, |
||||
CITALOPRAM, CITALOPRAM HYDROBROMIDE, |
||||
| 2086 | 25393930 |
IR |
2 | |
Toxicity to various agents, Serotonin syndrome, Overdose, |
||||
SERTRALINE, |
||||
| 2087 | 25394109 |
SE |
15 | 2 |
Suicidal ideation, Overdose, Sedation, Drug ineffective, Somnolence, Psychomotor hyperactivity, |
||||
ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, PROMETHAZINE, FLUOXETINE HYDROCHLORIDE, FLUOXETINE, OLANZAPINE, RISPERIDONE, RISPERIDONE, RISPERIDONE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, MELATONIN, SERTRALINE, |
||||
| 2088 | 25394158 |
US |
||
Overdose, Toxicity to various agents, Delirium, Urinary retention, Tachycardia, Dry mouth, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, |
||||
| 2089 | 25394162 |
US |
||
Overdose, Hallucination, Tachycardia, Agitation, Dry skin, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, OLANZAPINE, SENNOSIDES, SENNA LEAF, SENNA, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, |
||||
| 2090 | 25394164 |
US |
||
Overdose, Toxicity to various agents, Delirium, Hallucination, Urinary retention, Hyperhidrosis, Tachycardia, |
||||
DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, |
||||
| 2091 | 25394289 |
IR |
19 | 2 |
Electrocardiogram T wave inversion, Toxicity to various agents, Overdose, |
||||
SERTRALINE, |
||||
| 2092 | 25394404 |
GB |
45 | 1 |
CHANTER syndrome, Overdose, |
||||
PREGABALIN, METHADONE HYDROCHLORIDE, METHADONE, |
||||
| 2093 | 25394420 |
IR |
14 | 2 |
Toxicity to various agents, Seizure, Overdose, |
||||
SERTRALINE, |
||||
| 2094 | 25394562 |
SE |
15 | |
Overdose, Drug ineffective, |
||||
SERTRALINE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN 500MG, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ARIPIPRAZOLE ORALLY DISINTEGRATING, ARIPIPRAZOLE, ARIPIPRAZOLE ORAL, MELATONIN, HYDROXYZINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, |
||||
| 2095 | 25394754 |
US |
13 | 2 |
Acute kidney injury, Suicide attempt, Electrocardiogram QT prolonged, Hypothermia, Lactic acidosis, Pancreatitis, Cardiac dysfunction, Metabolic acidosis, Ventricular dysfunction, Aspartate aminotransferase increased, Alanine aminotransferase increased, Intentional overdose, Hyperlactacidaemia, Overdose, Multiple organ dysfunction syndrome, Myocardial injury, Toxicity to various agents, |
||||
METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SERTRALINE, |
||||
| 2096 | 25394836 |
US |
2 | |
Wrong technique in device usage process, Incorrect dose administered, Overdose, Drug ineffective, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FUROSEMIDE, |
||||
| 2097 | 25395027 |
IN |
21 | 1 |
Overdose, Coagulopathy, Blood lactic acid increased, Acute hepatic failure, Ammonia increased, Encephalopathy, Metabolic acidosis, Transaminases increased, Hyperbilirubinaemia, |
||||
FERROUS SULFATE, |
||||
| 2098 | 25395321 |
CN |
16 | 2 |
Toxicity to various agents, Overdose, Seizure, Coma, Bezoar, Shock, |
||||
VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, QUETIAPINE FUMARATE, QUETIAPINE, VALPROATE SODIUM, |
||||
| 2099 | 25395892 |
JP |
62 | 1 |
Toxicity to various agents, Circulatory collapse, Altered state of consciousness, Overdose, |
||||
AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, AMLODIPINE BESYLATE, |
||||
| 2100 | 25395922 |
JP |
60 | 1 |
Toxicity to various agents, Circulatory collapse, Altered state of consciousness, Overdose, |
||||
AMLODIPINE BESYLATE, CARVEDILOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-10-30